2m 2m 2m 2m 2m 2m 2m
Target Group (CBDY)
OTC
$0.001$0.00 (0.00%)
Price as of Oct 21, 2026- $617,025.00Market Cap
- -31.03%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Target Group (CBDY)
$0.001$0.00 (0.00%)
CBDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 500,000 | ||
30-Day Average Volume | 649,130 | ||
1-Week Change | 42.86% | ||
1-Month Change | 25.00% | ||
1-Year Change | -31.03% | ||
3-Year Change | -71.75% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 617.0M | ||
Total Assets | $5.7M | ||
Market Cap | $617,025.00 | ||
Enterprise Value | $7.9M | ||
Period: QTR TTM FY | |||
Revenue | $879,442.00 | ||
Net Income | -$550,356.00 | ||
Free Cash Flow | -$133,720.00 | ||
EBIT | -$550,347.00 | ||
EBITDA | -$320,694.00 | ||
Net Working Capital | -$11.3M | ||
EPS | -$0.00 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 9 | ||
P/B | -0 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue